A Phase II Study Designed to Evaluate the Value of Neoviderm Skin Emulsion in the Prevention of Radiation Dermatitis for Patients Undergoing External Radiation Therapy
A Phase II Study Designed to Evaluate the Value of Neoviderm Skin Emulsion in the Prevention of Radiation Dermatitis for Patients Undergoing External Radiation Therapy
The purpose of this study is to determine whether NeoVIDERM is effective at preventing radiation dermatitis in patients receiving external beam radiation therapy to the head and neck or breast areas.
Inclusion criteria: For patients receiving radiation to the breast
Inclusion criteria: For patients receiving radiation to the head and neck
Exclusion criteria: For patients receiving radiation to the breast or the head and neck
Patients that have a type V or type VI skin type according to the Fitzpatrick scale (because these patients will likely have less radiodermatitis and if they do, it will be harder to evaluate it).
The Fitzpatrick Scale:
Rarely burns, tans with ease
Allergic to any ingredient in Neoviderm cream